Triple

T22871194
Position Surface form Disambiguated ID Type / Status
Subject thioridazine E567199 entity
Predicate actsOnReceptor P9769 FINISHED
Object dopamine D2 receptor NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: dopamine D2 receptor | Statement: [thioridazine, actsOnReceptor, dopamine D2 receptor]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: dopamine D2 receptor
Context triple: [thioridazine, actsOnReceptor, dopamine D2 receptor]
  • A. Dopamine
    "Dopamine" is a 2015 studio album by American rock band Third Eye Blind, noted for its alternative rock sound and introspective lyrics.
  • B. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • C. M2 muscarinic acetylcholine receptor
    The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
  • D. mu-opioid receptor
    The mu-opioid receptor is a G protein–coupled receptor in the nervous system that mediates the powerful analgesic and euphoric effects of opioids as well as their major side effects, including respiratory depression and dependence.
  • E. CB1 receptor
    The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: dopamine D2 receptor
Target entity description: The dopamine D2 receptor is a G protein–coupled receptor in the brain that plays a key role in modulating dopamine signaling, influencing movement, motivation, and many psychiatric and neurological processes.
  • A. Dopamine
    "Dopamine" is a 2015 studio album by American rock band Third Eye Blind, noted for its alternative rock sound and introspective lyrics.
  • B. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • C. M2 muscarinic acetylcholine receptor
    The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
  • D. mu-opioid receptor
    The mu-opioid receptor is a G protein–coupled receptor in the nervous system that mediates the powerful analgesic and euphoric effects of opioids as well as their major side effects, including respiratory depression and dependence.
  • E. CB1 receptor
    The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e24589d8348190b96422d13a678bc1 completed April 17, 2026, 2:36 p.m.
NER Named-entity recognition batch_69f17f04b06481909004818ec8fc5a26 completed April 29, 2026, 3:46 a.m.
Created at: April 17, 2026, 3:38 p.m.